Fund Description
ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares Ultra Nasdaq Biotechnology
Fund Exchange Ticker BIB
Fund Sponsor ProShares
Fund ISIN US74347R2141
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Equity - Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Leveraged (2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 1 December 2023
Asset Under Management 76.82 Million (USD)
1 Month Total Return 5.26 %
Year To Date Return -19.42 %
1 Year Total Return -2.75 %
3 Year Annualized Total Return -14.42 %
NAV 46.5555
Share Outstanding 1,650,000
Top 10 Holdings (Invalid date)
Constituent Name Constituent Ticker Constituent Type Weighting